Compugen (CGEN) Common Equity (2009 - 2026)

Compugen (CGEN) has 18 years of Common Equity data on file, last reported at $95.4 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity rose 66.97% year-over-year to $95.4 million; the trailing twelve-month figure through Mar 2026 stood at $95.4 million (up 66.97% YoY), and the FY2025 full-year result was $102.7 million, up 87.08% from the prior year.
• Common Equity retreated to $95.4 million in Q1 2026, from $102.7 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $102.7 million in Q4 2025 to a low of $43.8 million in Q3 2025.
• A 5-year average of $69.3 million and a median of $62.0 million in 2023 frame the typical range for Common Equity.
• Across the five-year window, Common Equity tumbled 33.32% in 2023 and surged 87.08% in 2025, its largest moves.
• Tracing CGEN's Common Equity over 5 years: stood at $77.7 million in 2022, then slipped by 15.6% to $65.6 million in 2023, then decreased by 16.24% to $54.9 million in 2024, then soared by 87.08% to $102.7 million in 2025, then slipped by 7.18% to $95.4 million in 2026.
• Business Quant data shows CGEN's Common Equity at $95.4 million in Q1 2026, $102.7 million in Q4 2025, and $43.8 million in Q3 2025.